SCHEMBL16513747

SCHEMBL16513747

CN1CCN(c2ccc(Nc3ncc4cccc(-c5cccc(C=CC(N)=O)c5)c4n3)cc2C#N)CC1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.61
PAK1 Q13153 7/20 0.51
JAK2 O60674 3/20 0.48
BRD4 O60885 3/20 0.48
JAK1 P23458 1/20 0.48
BRD2 P25440 1/20 0.48
JAK3 P52333 1/20 0.48
BRD3 Q15059 1/20 0.48
BRDT Q58F21 1/20 0.48
FGFR1 P11362 2/20 0.47
KDR P35968 2/20 0.47
SLC2A1 P11166 2/20 0.47
PKMYT1 Q99640 2/20 0.46
PIM2 Q9P1W9 1/20 0.45
FGFR2 P21802 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16513994 0.90 EGFR (0.63) EGFRPAK1JAK2BRD4JAK3
SCHEMBL18527548 0.90 EGFR (0.49) EGFRPAK1JAK2BRD4JAK1
SCHEMBL16514436 0.90 EGFR (0.62) EGFRPAK1JAK2BRD4JAK1
SCHEMBL16514550 0.88 EGFR (0.61) EGFRPAK1JAK2BRD4JAK1
SCHEMBL16514587 0.84 FGFR1 (0.55) EGFRJAK2BRD4JAK1JAK3
SCHEMBL29847155 0.83 EGFR (0.79) EGFRPAK1JAK2BRD4JAK1
SCHEMBL16514504 0.83 EGFR (0.79) EGFRPAK1JAK2BRD4JAK1
Maleic Acid SCHEMBL16514328 0.81 FGFR1 (0.56) EGFRPAK1JAK2BRD4FGFR1
Fumaric Acid SCHEMBL16514259 0.81 FGFR1 (0.56) EGFRPAK1JAK2BRD4FGFR1
SCHEMBL18527556 0.80 EGFR (0.51) EGFRPAK1JAK2BRD4JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP disclosed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO disclosed